Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
GLAXOSMITHKLINE PLC Add to My Watchlist (NYSE: GSK) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     GLAXOSMITHKLIN 38.47 +0.35 (+0.92%) 3,263,709
980 Great West Road
Brentford, Middlesex, TW8 9GS EN
4402080475000
4402080477807 fax
www.gsk.com
CEO Andrew Witty
Auditor PricewaterhouseCoopers LLP
Exchange Traded NY
ISIN Number US37733W1053
CIK Number 1131399
NAICS Code 325412
Business Summary
A global healthcare Group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products including vaccines, over-the-counter medicines and health-related consumer products.
Number of Employees 99,003
Share Fundamentals
Market Cap 108.90B
Shares Outstanding 2.83B
Float N/A
Short Interest 4.67M
Financial Strength
Revenue (TTM) $24,736,491,000
Earnings (TTM) $4,215,746,000
Quick Ratio 1.2:1
Current Ratio 1.6:1
Total Debt/Equity 1.82:1
Dividend Information
Yield % 5.1
Annual Dividend 1.96
Latest Dividend 1.96 (2009-11-04)
Profitability
Gross Margin 82.3%
EBITDA Margin 31.8%
Profit Margin 24.7%
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Stock News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs